RNA biotech Nutcracker Therapeutics unshells $167M for drugs built on biochips March 14, 2022 Auto Bot ARCH Venture Partners, BioPharma, biopharma nl, California, deals, Emeryville, investing, mRNA, Pharma, Software, Startups 0 ARCH Venture Partners led the Series C round of financing for Nutcracker Therapeutics, a company developing new RNA drugs. The company’s process for developing and manufacturing RNA therapies borrows from techniques used in the technology sector.